-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
Nintedanib: a new treatment for idiopathic pulmonary fibrosis
Vincent Cottin
Drug Evaluation: Clinical Investigation
-
Allopurinol-thiopurine combination therapy in inflammatory bowel disease
Margien L Seinen, Nanne KH de Boer, Adriaan A van Bodegraven, Stephen B Hanauer & Frank Hoentjen
Special Report: Clinical Investigation
-
Allopurinol-thiopurine combination therapy in inflammatory bowel disease
Margien L Seinen, Nanne KH de Boer, Adriaan A van Bodegraven, Stephen B Hanauer & Frank Hoentjen
Special Report: Clinical Investigation
-
Allopurinol-thiopurine combination therapy in inflammatory bowel disease
Margien L Seinen, Nanne KH de Boer, Adriaan A van Bodegraven, Stephen B Hanauer & Frank Hoentjen
Special Report: Clinical Investigation
-
Allopurinol-thiopurine combination therapy in inflammatory bowel disease
Margien L Seinen, Nanne KH de Boer, Adriaan A van Bodegraven, Stephen B Hanauer & Frank Hoentjen
Special Report: Clinical Investigation
-
Allopurinol-thiopurine combination therapy in inflammatory bowel disease
Margien L Seinen, Nanne KH de Boer, Adriaan A van Bodegraven, Stephen B Hanauer & Frank Hoentjen
Special Report: Clinical Investigation
-
Allopurinol-thiopurine combination therapy in inflammatory bowel disease
Margien L Seinen, Nanne KH de Boer, Adriaan A van Bodegraven, Stephen B Hanauer & Frank Hoentjen
Special Report: Clinical Investigation
-
Pharmacodynamic end points in early phase oncology trials
Giovanna Speranza, James H Doroshow, Shivaani Kummar
Clinical Trail Perspective: Clinical Investigation
-
Pharmacodynamic end points in early phase oncology trials
Giovanna Speranza, James H Doroshow, Shivaani Kummar
Clinical Trail Perspective: Clinical Investigation
-
Pharmacodynamic end points in early phase oncology trials
Giovanna Speranza, James H Doroshow, Shivaani Kummar
Clinical Trail Perspective: Clinical Investigation
-
Pharmacodynamic end points in early phase oncology trials
Giovanna Speranza, James H Doroshow, Shivaani Kummar
Clinical Trail Perspective: Clinical Investigation
-
Pharmacodynamic end points in early phase oncology trials
Giovanna Speranza, James H Doroshow, Shivaani Kummar
Clinical Trail Perspective: Clinical Investigation
-
Pharmacodynamic end points in early phase oncology trials
Giovanna Speranza, James H Doroshow, Shivaani Kummar
Clinical Trail Perspective: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Incentives and barriers to neurological clinical research participation
Anne S Lindblad, Pam Zingeser, Nil Sismanyazici-Navaie
Research Article: Clinical Investigation
-
Emerging oral disease-modifying therapies in multiple sclerosis: a review of the latest clinical evidence
Esther V Hobson,Basil Sharrack
Review Article: Clinical Investigation
-
Emerging oral disease-modifying therapies in multiple sclerosis: a review of the latest clinical evidence
Esther V Hobson,Basil Sharrack
Review Article: Clinical Investigation
-
Emerging oral disease-modifying therapies in multiple sclerosis: a review of the latest clinical evidence
Esther V Hobson,Basil Sharrack
Review Article: Clinical Investigation
-
Emerging oral disease-modifying therapies in multiple sclerosis: a review of the latest clinical evidence
Esther V Hobson,Basil Sharrack
Review Article: Clinical Investigation
-
Emerging oral disease-modifying therapies in multiple sclerosis: a review of the latest clinical evidence
Esther V Hobson,Basil Sharrack
Review Article: Clinical Investigation
-
Emerging oral disease-modifying therapies in multiple sclerosis: a review of the latest clinical evidence
Esther V Hobson,Basil Sharrack
Review Article: Clinical Investigation